Skip to main content
Fig. 5 | Journal of Ovarian Research

Fig. 5

From: Comparative efficacy and safety of metformin, anti-obesity agents, and myoinositol in improving IVF/ICSI outcomes and reducing ovarian hyperstimulation syndrome in women with polycystic ovary syndrome: a systematic review and network meta-analysis

Fig. 5

Netleague of primary outcomes for subgroup analysis (by protocol). (A) Netleague of clinical pregnancy and abortion of agonist protocol group (B) Netleague of OHSS of agonist protocol group (C) Netleague of clinical pregnancy and OHSS of antagonist protocol group. The comparisons of data are odds ratios (95% CI), which should be read from left to right. Odds ratio higher than 1 favor the left treatments, lower than 1 favor the right treatments. Significant results are in bold and underlined. OHSS: ovarian hyperstimulation syndrome

Back to article page